B. Metzler seel. Sohn & Co. AG
Position in DNLI — Denali Therapeutics Inc.
CIK 1847838
FRANKFURT, 2M
Position in DNLI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,888,356
+$732,196 QoQ
Shares Held
112,300
0.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#83
of 290 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026B. Metzler seel. Sohn & Co. AG holds $150,123,352 across 18 Biotechnology names. DNLI ranks #4 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
231,381 | $114,933,882 | |
| 2 | INSM |
INSMED Inc
|
40,521 | $4,320,349 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,591 | $3,188,207 | |
| 4 | DNLI |
Denali Therapeutics Inc.
This page
|
112,300 | $2,888,356 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,472 | $2,788,470 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
13,605 | $2,547,944 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
9,241 | $2,261,919 | |
| 8 | TECH |
BIO-TECHNE Corp
|
31,091 | $2,196,579 |
All Filings in DNLI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,888,356 | 112,300 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $2,156,160 | 112,300 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,854,073 | 112,300 | Shares | Defined | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||